Yngvil Solheim Husum

4PUBLICATIONS
3CO-AUTHORS
Optical technologyPredictive and prognostic markersNeurology and neuromuscular diseasesMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 08, 2026
Impact of faricimab and high-dose aflibercept on treatment demand in a tertiary ophthalmic centre in Norway.

|Dec 25, 2024
Zoledronic acid as adjuvant therapy in neovascular age-related macular degeneration: a randomised controlled pilot study.

Yngvil Solheim Husum, Morten Carstens Moe, Morten Wang Fagerland

|Dec 10, 2023
Intravitreal anti-vascular endothelial growth factor therapy for retinal diseases in Norway from 2011 to 2021: A combined registry and survey study.

Yngvil Solheim Husum, Ragnhild Haugli Bråten, Erik Magnus Sæther

|Feb 27, 2021
Switching to aflibercept versus continuing bevacizumab for treatment-resistant neovascular age-related macular degeneration: a one-year comparative observational study.

Yngvil Solheim Husum, Morten Carstens Moe, Ragnheiður Bragadóttir

Pageof 1

Frequent Collaborators

4 joint publications

Øystein Kalsnes Jørstad

1 joint publications

Ivar Sønbø Kristiansen

1 joint publications

Thea Blix